Andrey Borisov

2.8k total citations · 1 hit paper
25 papers, 2.1k citations indexed

About

Andrey Borisov is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Andrey Borisov has authored 25 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Andrey Borisov's work include Tuberculosis Research and Epidemiology (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Infectious Diseases and Tuberculosis (5 papers). Andrey Borisov is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Infectious Diseases and Tuberculosis (5 papers). Andrey Borisov collaborates with scholars based in United States, Russia and Spain. Andrey Borisov's co-authors include Bobbi J. Woolwine, Andrew H. Miller, Charles L. Raison, Margarita E. Villarino, Gerald Vogt, Timothy R. Sterling, Charles B. Nemeroff, Stephen E. Weis, Amy Kerrigan and Sherry D. Broadwell and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Andrey Borisov

21 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

2011 630 citations Timothy R. Sterling, Margarita E. Villarino et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrey Borisov United States	14	1.0k	1.0k	551	521	413	25	2.1k
Geert Robaeys Belgium	22	1.2k 1.2×	191 0.2×	558 1.0×	57 0.1×	398 1.0×	94	2.1k
Daniel Forton United Kingdom	22	1.5k 1.4×	206 0.2×	247 0.4×	100 0.2×	90 0.2×	53	2.4k
Martin Schaefer Germany	25	1.0k 1.0×	171 0.2×	401 0.7×	42 0.1×	216 0.5×	71	2.3k
Michael R. Kraus Germany	22	753 0.7×	65 0.1×	269 0.5×	139 0.3×	157 0.4×	53	1.6k
Janet L. Cunningham Sweden	25	398 0.4×	212 0.2×	205 0.4×	79 0.2×	94 0.2×	82	1.8k
Jennifer R. King United States	19	328 0.3×	469 0.5×	49 0.1×	99 0.2×	55 0.1×	61	1.9k
Bruce H. Phelps United States	21	766 0.7×	245 0.2×	87 0.2×	77 0.1×	15 0.0×	42	1.7k
Riccardo De Giorgi Italy	16	195 0.2×	96 0.1×	76 0.1×	240 0.5×	47 0.1×	59	949
Eric Dieperink United States	22	1.2k 1.1×	75 0.1×	218 0.4×	16 0.0×	117 0.3×	36	1.7k
Qingyan Ma China	18	256 0.3×	334 0.3×	110 0.2×	25 0.0×	38 0.1×	50	876

Countries citing papers authored by Andrey Borisov

Since Specialization

Citations

This map shows the geographic impact of Andrey Borisov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrey Borisov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrey Borisov more than expected).

Fields of papers citing papers by Andrey Borisov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrey Borisov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrey Borisov. The network helps show where Andrey Borisov may publish in the future.

Co-authorship network of co-authors of Andrey Borisov

This figure shows the co-authorship network connecting the top 25 collaborators of Andrey Borisov. A scholar is included among the top collaborators of Andrey Borisov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrey Borisov. Andrey Borisov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Borisov, Andrey, et al.. (2025). Evaluation of the effectiveness of pharmacotherapy in intensive care patients with erosive and ulcerative lesions of the gastroduodenal zone of mixed genesis complicated by bleeding. Messenger of Anesthesiology and Resuscitation. 22(3). 129–135.

2.

Moro, Ruth N., Carolina Mehaffy, Prithwiraj De, et al.. (2024). Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing Flu-Like Reactions During Treatment of Latent Tuberculosis Infection. The Journal of Infectious Diseases. 230(5). 1271–1278.

3.

Winters, Nicholas, Robert Belknap, Andrea Benedetti, et al.. (2023). Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis. The Lancet Respiratory Medicine. 11(9). 782–790. 12 indexed citations

4.

Weston, Emily, Andrey Borisov, Eileen F. Dunne, et al.. (2023). Neisseria gonorrhoeae antimicrobial susceptibility trends in Bangkok, Thailand, 2015–21: Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP). JAC-Antimicrobial Resistance. 5(6). dlad139–dlad139. 3 indexed citations

5.

Khoreshok, Alexey A., et al.. (2019). Justification of the Disk Tool Application for Working Bodies of Mining Machines. SHILAP Revista de lepidopterología. 297. 3007–3007. 1 indexed citations

6.

Borisov, Andrey, Sapna Bamrah Morris, Gibril J. Njie, et al.. (2018). Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat LatentMycobacterium tuberculosisInfection. MMWR Morbidity and Mortality Weekly Report. 67(25). 723–726. 68 indexed citations

7.

Njie, Gibril J., Sapna Bamrah Morris, Rachel Yelk Woodruff, et al.. (2018). Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis. American Journal of Preventive Medicine. 55(2). 244–252. 55 indexed citations

8.

Belknap, Robert, David P. Holland, Pei-Jean Feng, et al.. (2017). Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection. Annals of Internal Medicine. 167(10). 689–697. 103 indexed citations

9.

Moro, Ruth N., Andrey Borisov, Jussi Saukkonen, et al.. (2016). Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada. Clinical Infectious Diseases. 62(11). 1390–1400. 33 indexed citations

10.

Sterling, Timothy R., Ruth N. Moro, Andrey Borisov, et al.. (2015). Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study. Clinical Infectious Diseases. 61(4). 527–535. 80 indexed citations

11.

Marks, Suzanne M., Harrell W. Chesson, Amy Kerrigan, et al.. (2013). Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States. The International Journal of Tuberculosis and Lung Disease. 17(12). 1531–1537. 54 indexed citations

12.

Sterling, Timothy R., Margarita E. Villarino, Andrey Borisov, et al.. (2011). Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection. New England Journal of Medicine. 365(23). 2155–2166. 630 indexed citations breakdown →

13.

Raison, Charles L., Andrey Borisov, Matthias Majer, et al.. (2008). Activation of Central Nervous System Inflammatory Pathways by Interferon-Alpha: Relationship to Monoamines and Depression. Biological Psychiatry. 65(4). 296–303. 306 indexed citations

14.

Evans, Dabney P., et al.. (2008). Shattered Shangri-la: differences in depressive and anxiety symptoms in students born in Tibet compared to Tibetan students born in exile. Social Psychiatry and Psychiatric Epidemiology. 43(6). 429–436. 9 indexed citations

15.

Evans, Dabney P., et al.. (2008). Shattered Shangri-la: differences in depressive and anxiety symptoms in students born in Tibet compared to Tibetan students born in exile. Social Psychiatry and Psychiatric Epidemiology. 43(7). 592–592.

16.

Raison, C L, et al.. (2008). Interferon-α effects on diurnal hypothalamic–pituitary–adrenal axis activity: relationship with proinflammatory cytokines and behavior. Molecular Psychiatry. 15(5). 535–547. 156 indexed citations

17.

Raison, Charles L., Bobbi J. Woolwine, Andrey Borisov, et al.. (2007). Paroxetine for prevention of depressive symptoms induced by interferon‐alpha and ribavirin for hepatitis C. Alimentary Pharmacology & Therapeutics. 25(10). 1163–1174. 114 indexed citations

18.

Wang, Xiaofang, Andrey Borisov, Bobbi J. Woolwine, et al.. (2006). Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: A switch study. Journal of Psychiatric Research. 40(7). 669–676. 29 indexed citations

19.

Raison, Charles L., Andrey Borisov, Sherry D. Broadwell, et al.. (2005). Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy. The Journal of Clinical Psychiatry. 66(1). 41–48. 249 indexed citations

20.

Raison, Charles L., Sherry D. Broadwell, Andrey Borisov, et al.. (2004). Depressive symptoms and viral clearance in patients receiving interferon-α and ribavirin for hepatitis C. Brain Behavior and Immunity. 19(1). 23–27. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact